BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26613555)

  • 1. Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History.
    Delgado JF; Alonso-Pulpón L; Mirabet S; Almenar L; Villa FP; González-Vílchez F; Palomo J; Blasco T; Dolores García-Cosio M; González-Costello J; de la Fuente L; Rábago G; Lage E; Pascual D; Molina BD; Arizón JM; Muñiz J; Crespo-Leiro MG
    Am J Transplant; 2016 May; 16(5):1569-78. PubMed ID: 26613555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy after heart transplantation: incidence, prognosis and risk factors.
    Crespo-Leiro MG; Alonso-Pulpón L; Vázquez de Prada JA; Almenar L; Arizón JM; Brossa V; Delgado JF; Fernandez-Yañez J; Manito N; Rábago G; Lage E; Roig E; Diaz-Molina B; Pascual D; Muñiz J
    Am J Transplant; 2008 May; 8(5):1031-9. PubMed ID: 18416739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.
    Alvarez-Alvarez RJ; Barge-Caballero E; Chavez-Leal SA; Paniagua-Martin MJ; Marzoa-Rivas R; Caamaño CB; López-Sainz Á; Grille-Cancela Z; Blanco-Canosa P; Herrera-Noreña JM; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
    J Heart Lung Transplant; 2015 Feb; 34(2):167-74. PubMed ID: 25434523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry.
    Sagastagoitia-Fornie M; Morán-Fernández L; Blázquez-Bermejo Z; Díaz-Molina B; Gómez-Bueno M; Almenar-Bonet L; López-Granados A; González-Vílchez F; Mirabet-Pérez S; García-Romero E; Jose M SM; Rábago Juan-Aracil G; Castel-Lavilla MA; Blasco-Peiro T; Garrido-Bravo I; De La Fuente-Galán L; Muñiz J; Crespo-Leiro MG
    Transpl Int; 2023; 36():11042. PubMed ID: 37275465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant malignancy as a risk factor for posttransplant malignancy after heart transplantation.
    Yoosabai A; Mehta A; Kang W; Chaiwatcharayut W; Sampaio M; Huang E; Bunnapradist S
    Transplantation; 2015 Feb; 99(2):345-50. PubMed ID: 25606783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
    Bergenfeldt H; Andersson B; Bućin D; Stehlik J; Edwards L; Rådegran G; Nilsson J
    J Heart Lung Transplant; 2015 Jul; 34(7):892-8. PubMed ID: 25754241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence and mortality after heart transplantation - A population-based national cohort study.
    Jäämaa-Holmberg S; Salmela B; Lemström K; Pukkala E; Lommi J
    Acta Oncol; 2019 Jun; 58(6):859-863. PubMed ID: 30821595
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of heart transplantation in patients with human immunodeficiency virus.
    Madan S; Patel SR; Saeed O; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    Am J Transplant; 2019 May; 19(5):1529-1535. PubMed ID: 30614612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wasting or obesity at time of transplant does not predict pediatric heart transplant outcomes: analysis of ISHLT pediatric heart transplant registry.
    Kaufman BD; Chuai S; Dobbels F; Shaddy RE
    J Heart Lung Transplant; 2009 Dec; 28(12):1273-8. PubMed ID: 19783177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The falling incidence of hematologic cancer after heart transplantation.
    Crespo-Leiro MG; Delgado-Jiménez J; López L; Alonso-Pulpón L; González-Vilchez F; Almenar-Bonet L; Rábago G; Pérez-Villa F; Paniagua Martín MJ; Arizón Del Prado JM; Sousa-Casasnovas I; Manito-Lorite N; Díaz-Molina B; Pascual-Figal D; Lage-Galle E; Blasco-Peiró T; De la Fuente-Galán L; Muñiz J
    Clin Transplant; 2014 Oct; 28(10):1142-7. PubMed ID: 25100534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of short-term mechanical circulatory support with extracorporeal devices on postoperative outcomes after emergency heart transplantation: data from a multi-institutional Spanish cohort.
    Barge-Caballero E; Almenar-Bonet L; Villa-Arranz A; Pérez-Villa F; Segovia-Cubero J; Delgado-Jiménez J; González-Vilchez F; Manito-Lorite N; De-la-Fuente-Galán L; Brossa-Loidi V; Lambert-Rodríguez JL; Pascual-Figal D; Lage-Gallé E; Arizón-Del-Prado JM; Sanz-Julve M; Muñiz-García J; Crespo-Leiro M
    Int J Cardiol; 2014 Sep; 176(1):86-93. PubMed ID: 25034802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients.
    Thibodeau JT; Mishkin JD; Patel PC; Kaiser PA; Ayers CR; Mammen PP; Markham DW; Ring WS; Peltz M; Drazner MH
    Clin Transplant; 2012; 26(6):953-9. PubMed ID: 22775970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer after heart transplantation: results from a large multicenter registry.
    Crespo-Leiro MG; Villa-Arranz A; Manito-Lorite N; Paniagua-Martin MJ; Rábago G; Almenar-Bonet L; Alonso-Pulpón L; Mirabet-Pérez S; Diaz-Molina B; González-Vilchez F; Arizón de Prado JM; Romero-Rodriguez N; Delgado-Jimenez J; Roig E; Blasco-Peiró T; Pascual-Figal D; De la Fuente Galán L; Muñiz J
    Am J Transplant; 2011 May; 11(5):1035-40. PubMed ID: 21521471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database.
    Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T
    Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults.
    Zalawadiya S; Fudim M; Bhat G; Cotts W; Lindenfeld J
    J Heart Lung Transplant; 2017 Jan; 36(1):77-81. PubMed ID: 27866925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies.
    Batra J; DeFilippis EM; Golob S; Clerkin K; Topkara VK; Habal MV; Restaino S; Griffin J; Hi Lee S; Latif F; Farr MA; Sayer G; Raikelkar J; Uriel N
    Circ Heart Fail; 2022 Apr; 15(4):e008968. PubMed ID: 35094567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical Characteristics, Complications, and Outcomes in Recipients Having Heart Transplants <65 Years of Age Versus ≥65 Years of Age.
    Jamil A; Qin H; Felius J; Saracino G; Rafael AE; MacHannaford JC; Gonzalez-Stawinski GV; Lima B
    Am J Cardiol; 2017 Dec; 120(12):2207-2212. PubMed ID: 29056228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.